Keywords: sciele, licenses, plethora, pe, drug, buys, 7m

Sciele licenses Plethora's PE drug and buys $7M stake

Article | 28 May 2007

Print This

The USA's Sciele Pharma has licensed the exclusive marketing rights to UK-based Plethora Solutions' PSD502 for premature ejaculation in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in